Evidence map›Paper›PMID 39852166›Full record

ArticleCurrent issues in molecular biology2025

Triterpenoids from Chios Mastiha Resin Against MASLD-A Molecular Docking Survey.

Nataša Milošević, Maja Milanović, Milica Medić Stojanoska, Varomyalin Tipmanee, Ilias Smyrnioudis, George V Dedoussis, Nataša Milić

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. PreliminaryLife (Basel, Switzerland) · 2026
    Article
  2. Insight into the Hypoglycemic Effects ofPlants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. The effects of terpenes on metabolism: a comprehensive review on recent updates.Current opinion in clinical nutrition and metabolic care · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nataša MiloševićDepartment of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-5286-3858
Maja MilanovićDepartment of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0003-4082-5480
Milica Medić StojanoskaFaculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
Varomyalin TipmaneeDepartment of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID 0000-0001-6017-7519
Ilias SmyrnioudisChios Mastic Gum Growers Association, 82150 Chios, Greece.ORCID 0000-0003-2431-9369
George V DedoussisDepartment of Nutrition and Dietetics, School of Health Science and Education, Harokopio University of Athens, 17671 Athens, Greece.ORCID 0000-0002-7798-6221
Nataša MilićDepartment of Pharmacy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0002-8595-6065

Funding

Pokrajinski Sekretarijat za Nauku i Tehnološki Razvoj 003076431 2024 09418 003 000 000 001
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease without an approved pharmacological approach for its prevention/treatment. Based on the modified Delphi process, NAFLD was redefined as metabolic dysfunction-associated steatotic liver disease (MASLD) to highlight the metabolic aspect of liver pathogenesis. Chios mastiha (

Indexed as

antiobesitybiological activitymolecular dockingmolecular targetnatural compoundsnon-alcoholic liver disease

Identifiers

PMID39852166
PMCPMC11763944

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.